Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

507 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis.
Shitaoka K, Hamana H, Kishi H, Hayakawa Y, Kobayashi E, Sukegawa K, Piao X, Lyu F, Nagata T, Sugiyama D, Nishikawa H, Tanemura A, Katayama I, Murahashi M, Takamatsu Y, Tani K, Ozawa T, Muraguchi A. Shitaoka K, et al. Among authors: takamatsu y. Cancer Immunol Res. 2018 Apr;6(4):378-388. doi: 10.1158/2326-6066.CIR-17-0489. Epub 2018 Feb 23. Cancer Immunol Res. 2018. PMID: 29475880
Clinical and cytopathological characteristics of HTLV-1+ hodgkin lymphoma.
Kobata K, Kimura S, Mihashi Y, Iwasaki H, Nonaka S, Matsumoto S, Takamatsu Y, Choi I, Kawauchi S, Ishitsuka K, Takeshita M. Kobata K, et al. Among authors: takamatsu y. Cancer Med. 2020 Aug;9(16):5788-5797. doi: 10.1002/cam4.3139. Epub 2020 Jun 28. Cancer Med. 2020. PMID: 32597011 Free PMC article.
Programmed cell death-ligand 1 (PD-L1)+ tumour cells and low-reacting programmed cell death 1 (PD1)+ tumour-infiltrating lymphocytes predict poor prognosis in Epstein-Barr virus+ diffuse large B-cell lymphoma.
Kimura S, Oshiro Y, Iwasaki H, Kadowaki M, Mihashi Y, Sakata T, Kawauchi S, Wang Z, Takamatsu Y, Takeshita M. Kimura S, et al. Among authors: takamatsu y. Clin Exp Med. 2022 Aug;22(3):411-419. doi: 10.1007/s10238-021-00754-4. Epub 2021 Sep 13. Clin Exp Med. 2022. PMID: 34515880
Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies.
Ogura M, Uchida T, Terui Y, Hayakawa F, Kobayashi Y, Taniwaki M, Takamatsu Y, Naoe T, Tobinai K, Munakata W, Yamauchi T, Kageyama A, Yuasa M, Motoyama M, Tsunoda T, Hatake K. Ogura M, et al. Among authors: takamatsu y. Cancer Sci. 2015 Jul;106(7):896-901. doi: 10.1111/cas.12683. Epub 2015 May 25. Cancer Sci. 2015. PMID: 25912076 Free PMC article. Clinical Trial.
Multiple lesions of gastrointestinal tract invasion by monomorphic epitheliotropic intestinal T-cell lymphoma, accompanied by duodenal and intestinal enteropathy-like lesions and microscopic lymphocytic proctocolitis: a case series.
Ishibashi H, Nimura S, Kayashima Y, Takamatsu Y, Aoyagi K, Harada N, Kadowaki M, Kamio T, Sakisaka S, Takeshita M. Ishibashi H, et al. Among authors: takamatsu y. Diagn Pathol. 2016 Jul 25;11(1):66. doi: 10.1186/s13000-016-0519-x. Diagn Pathol. 2016. PMID: 27457239 Free PMC article.
Diagnosis and treatment of bone metastasis: comprehensive guideline of the Japanese Society of Medical Oncology, Japanese Orthopedic Association, Japanese Urological Association, and Japanese Society for Radiation Oncology.
Shibata H, Kato S, Sekine I, Abe K, Araki N, Iguchi H, Izumi T, Inaba Y, Osaka I, Kato S, Kawai A, Kinuya S, Kodaira M, Kobayashi E, Kobayashi T, Sato J, Shinohara N, Takahashi S, Takamatsu Y, Takayama K, Takayama K, Tateishi U, Nagakura H, Hosaka M, Morioka H, Moriya T, Yuasa T, Yurikusa T, Yomiya K, Yoshida M. Shibata H, et al. Among authors: takamatsu y. ESMO Open. 2016 Mar 16;1(2):e000037. doi: 10.1136/esmoopen-2016-000037. eCollection 2016. ESMO Open. 2016. PMID: 27843593 Free PMC article. Review.
BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study.
Miyamoto S, Yotsumoto F, Ueda T, Fukami T, Sanui A, Miyata K, Nam SO, Fukagawa S, Katsuta T, Maehara M, Kondo H, Miyahara D, Shirota K, Yoshizato T, Kuroki M, Nishikawa H, Saku K, Tsuboi Y, Ishitsuka K, Takamatsu Y, Tamura K, Matsunaga A, Hachisuga T, Nishino S, Odawara T, Maeda K, Manabe S, Ishikawa T, Okuno Y, Ohishi M, Hikita T, Mizushima H, Iwamoto R, Mekada E. Miyamoto S, et al. Among authors: takamatsu y. BMC Cancer. 2017 Jan 31;17(1):89. doi: 10.1186/s12885-017-3071-5. BMC Cancer. 2017. PMID: 28143428 Free PMC article. Clinical Trial.
507 results